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The human cytomegalovirus immediate-early gene product 2 (IE2) is able to transactivate homologous and
heterologous promoters alone or augmented by immediate-early gene product 1 (IE1). IE2 has also been shown
to autoregulate the major immediate-early promoter by directly binding to a cis repression signal located
between the TATA box and the cap site. However, IE2 has not been shown to act directly through a specific
DNA sequence in transactivating various promoters. To understand whether IE2 can be indirectly involved in
DNA sequence-specific transactivation through interactions with other transcriptional factors, we performed a
study of the interactions of IE2 with cellular proteins. In order to study these interactions, IE cDNAs were
subcloned into a bacterial expression vector, pGEX2T, by polymerase chain reaction amplification to produce
fusion proteins which were full-length as well as proteins which contained various functional domains. We were
able to demonstrate IE2's ability to interact directly or indirectly with several cellular proteins ranging from
>200 to 14 kDa through glutathione S-transferase-fusion protein precipitation and far-Western analysis. These
interactions have been mapped to domains within IE2 which are known to be necessary for either
transactivation or both transactivation and autoregulation. All of the IE2-associated proteins are nuclear
proteins, and a subset are phosphorylated. In vitro-synthesized 35S-IE2 protein and bacterially expressed IE2
fusion proteins were used to study IE2-IE2 interaction by binding assay and far-Western analysis. IE2-IE2
interactions were mapped to a domain containing a putative helix-turn-helix motif located near the C terminus
of IE2, between amino acids 456 and 539. However, IE2 was unable to directly interact with either IEl, an
alternatively spliced variant of IE2 (55 kDa), or IE2 deletion mutants that did not contain the multimerization
domain.
Like the genomes of all members of the herpesvirus
family, the viral genome of human cytomegalovirus (HCMV)
is expressed in a sequential fashion. HCMV lytic gene
expression is divided into three categories: immediate-early
(IE), early, and late (10, 42, 68, 69). IE gene expression
which occurs in the absence of de novo protein synthesis
includes the major IE (1, 24, 56, 58), UL36-38 (28, 62, 63,
71), and US3 (70) genes. The major IE region consists of two
transcription units, IE1 and IE2, located downstream of the
major IE promoter (MIEP) (56-58). The IEl transcription
unit consists of the first four exons and codes for a 1.95-kb
mRNA that translates into a 72-kDa protein (56, 58). The
second transcriptional unit, designated IE2, includes exons 1
through 3 and exon 5. Transcripts produced from this region
encode several mRNAs of 2.25, 1.70, and 1.40 kb and, upon
translation, result in proteins of 84, 55, and 40 kDa, respec-
tively (54, 56-58). All of the major IE proteins share a N
terminus of 85 amino acids derived from exons 2 and 3, with
the exception of the 40-kDa protein that originates solely
from exon 5 (57). Interestingly, the functional characteristics
of the different IE proteins differ dramatically even though
they share many domains.
IE1 has been shown to function as a transactivator of the
MIEP via NF-KB (7, 51). Additionally, IE1 transactivates
several heterologous promoters and augments the transacti-
vation activity of the 84-kDa IE2 protein on various cellular
and viral promoters (4, 11, 15, 17, 19, 41, 49, 53, 64, 67). The
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domains in IE2 which are required for transactivation are
located between amino acids 1 and 97 and between amino
acids 195 and 579 (41, 48, 49, 55). Autoregulation of the
MIEP through the C-terminal half of IE2 (amino acids 290 to
579) occurs via a cis repression signal (CRS) located between
the TATA box and the transcription start site (18, 39, 47-49,
55). Recently, IE2 has been demonstrated to bind directly to
the CRS element (35).
An alternatively spliced version of IE2, the 55-kDa protein
(54), appears to function as a transcriptional activator of the
MIEP, probably by a mechanism other than directly through
the CRS element (2), and seems to be incapable of activating
expression of many early genes (41, 48, 55). The primary
difference between the 84- and 55-kDa proteins is an internal
deletion of amino acids 365 to 519. Thus, the abilities of the
84-kDa IE2 protein to transactivate heterologous and homol-
ogous promoters as well as downregulate the MIEP correlate
with the deleted region in the 55-kDa protein. These conclu-
sions have been further documented through the use of
insertional mutations of IE2 in transient transfection assays
(2, 55). An N-terminal truncation of IE2, the 40-kDa protein
(amino acids 341 to 579), which is expressed at late times of
infection (54), retains only the downregulation function (18,
47, 49).
Identification of protein-protein interactions between cel-
lular and/or viral proteins with IE2 is the first step in
understanding the mechanisms utilized by the various forms
of IE2 to transactivate and autoregulate promoters. In the
present study, we set out to (i) determine whether IE2
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specifically interacts with cellular and/or viral proteins, (ii)
identify the domains of IE2 responsible for these interac-
tions, and (iii) demonstrate which cellular proteins directly
interact with IE2. To study protein-protein interactions
between IE2 and cellular proteins, a fusion protein binding
assay consisting of a glutathione S-transferase (GST)-IE2
chimera protein incubated with precleared, labeled lysates
was employed. This procedure, which has been successfully
utilized by others (5, 26), would allow for the detection of
both weak and strong protein-protein interactions. Through
this assay, we were able to identify several protein-protein
interactions between IE2 and cellular proteins ranging from
>200 to 14 kDa. Chimeric IE2 deletion constructs that were
based on the known domains required for transactivation,
autoregulation, or both allowed for the localization of re-
gions in IE2 required for these protein-protein interactions.
Through far-Western analysis, a subset of cellular proteins
directly interacting with IE2 was detected. Serendipitously,
IE2 was found to interact with another IE2 molecule through
a C-terminal domain that contains two putative amphiphilic
oa-helices separated by a short ,B-turn. Oligomerization be-
tween IE2 and IEl or the 55-kDa IE2 protein, which does
not encode the required C-terminal domain, was not de-
tected.
MATERIALS AND METHODS
Cell culture. HCMV Towne strain, passages 36 to 39, was
propagated as described previously (21). Human embryonic
lung fibroblasts (HEL) were grown in Dulbecco's modified
minimal essential medium with high glucose (DMEM-H)
supplemented with 10% fetal bovine serum and penicillin-
streptomycin.
Radioisotopic labeling. HEL cultures grown to 80% con-
fluency were fed fresh medium 24 h prior to labeling with
either [35S]methionine (1,200 Ci/mmol; Dupont, NEN Re-
search Products, Boston, Mass.) or 32Pi (Pi, 285 Ci/mg; ICN,
Costa Mesa, Calif.). For 35S labeling, HEL cells were
washed twice with phosphate-buffered saline (PBS [pH 7.5])
(80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM NaCl) and
incubated in methionine-free medium supplemented with 2%
fetal bovine serum and [35S]methionine (100 ,Ci/ml of me-
dium) for 24 h. For 32p labeling, HEL cells were washed
twice with Tris-buffered saline (TBS) (25 mM Tris [pH 8.0],
150 mM NaCl) and preincubated in phosphate-free
DMEM-H supplemented with 2% dialyzed fetal bovine
serum for 2 h. Fresh phosphate-free medium supplemented
with 2% dialyzed fetal bovine serum and 32Pi (830 ,Ci/ml of
medium) was added to cells, and the mixture was incubated
for 3 to 4 h. Labeled cells were then washed twice with either
ice-cold PBS or TBS and scraped from the surface of the
roller bottles in 20 ml of buffer. The cells were then pelleted
and washed once more. The cell pellet was resuspended in 1
ml of ice-cold EBC buffer (50 mM Tris [pH 8.0], 120 mM
NaCl, 0.5% Nonidet P-40, 100 mM NaF, 200 ,uM sodium
orthovanadate supplemented with aprotonin [Sigma, St.
Louis, Mo.] and leupeptin [Boehringer Mannheim, Indianap-
olis, Ind.] [10 ,ug/ml each], 1 mM phenylmethylsulfonyl
fluoride [PMSF] [Sigma]) and incubated at 4°C for 1 h. The
debris was removed by microcentrifugation for 20 min at
4°C. The supernatant was aliquoted and stored at -70°C.
Labeling efficiency was determined by trichloroacetic acid
precipitation.
For 35S-labeled, infected HEL lysate, HEL cultures
grown to 80% confluency were fed 24 h prior to HCMV
infection and labeling with [35S]methionine. Before being
labeled, HEL cultures were infected with a multiplicity of
infection of 2 for 2 h. The medium was removed and replaced
with medium supplemented with [35S]methionine (100
,Ci/ml of medium) for 24 h and processed as described
above.
Cytoplasmic and nuclear fractions from 35S-labeled cells
were prepared essentially as described previously (12). Fol-
lowing3S labeling, HEL cells were scraped and suspended
in ice-cold PBS. The cells were pelleted and washed twice
with PBS. The cell pellet was resuspended in PCV buffer {10
mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid] [pH 7.9], 0.75 mM spermidine, 0.15 mM
spermine, 0.1 mM EDTA, 0.1 mM EGTA [ethylene glycol-
bis(,B-aminoethyl ether)-N,N,N',N'-tetraacetic acid] 1 mM
dithiothreitol [DTT], 10 mM KCI, 100 mM NaF, 200 ,uM
sodium orthovanadate, 10 p,g of aprotonin per ml, 10 ,ug of
leupeptin per ml, 1 mM PMSF}, incubated on ice for 10 min,
and pelleted. The cells were resuspended in PCV buffer and
Dounce homogenized briefly. The suspension was centri-
fuged at 16,000 rpm in a Sorvall HB4 rotor, and the cyto-
plasmic fraction was removed and stored at -70°C. The
pellet was resuspended in 1 ml of nuclear resuspension
buffer (20 mM HEPES [pH 7.9], 0.75 mM spermidine, 0.15
mM spermine, 0.2 mM EDTA, 2 mM EGTA, 2 mM DTT,
20% glycerol, 10 ,ug of aprotonin per ml, 10 ,ug of leupeptin
per ml, and 1 mM PMSF) for every 109 cells and incubated
on ice for 20 min with agitation. NaCl was added to a final
concentration of 0.4 M to solubilize the nuclei, and the
extract was centrifuged at 150,000 x g for 90 min. The
nuclear extract was dialyzed twice against 20 mM dialysis
buffer (20% glycerol, 100 mM KCl, 12.5 mM MgCl2, 0.2 mM
EDTA, 0.2 mM EGTA, 2 mM DTT, 1 mM PMSF), and
aliquots were stored at -70°C.
GST fusion constructions. pGEX.IE1, pGEX.IE2-55K,
pGEX.IE2-84K, pGEX.IE2.1-539, pGEX.IE2.1-291, pGEX.
IE2.1-100, pGEX.IE2.97-579, pGEX.IE2.97-539, pGEX.
IE2.97-456, pGEX.IE2.285-539, and pGEX.IE2.532-579 (the
amino acid coding region of each construct is indicated by
the number after pGEX.IE2) were cloned by polymerase
chain reaction (PCR) amplification of the appropriate coding
regions from IE cDNA clones pGEM4-1T (IE1), pGEM4-2T
(IE2; 84 kDa), and pRSVIE2-55 (IE2; 55 kDa; gift from Jay
Nelson) with combinations of the following primers:
5'IE1&2, 5' ACGAATTCGGATCCATGGAGTCCTCTGC
CAAGAG 3'; 5'IE2.97, 5' ACGAATTCGGIATCCATGG
TATCGATTCCAGTAGC 3'; 5'IE2.285, 5' ACGAATTCG
GATCCATGGCATCCGTGACCTCGAGC 3'; 5'IE2.532, 5'
ACGAATTCGGATCCATGTTCATGCTGCCTATCTAC
GAG 3'; 3'IE1, 5' ACGAATTCQiATC_CIAflAGTGG
GATCCATAACAGTAAC 3'; 3'IE2, 5' ACGAATTCGGA
TCCTG3AfACTGAGACTTGTTCCTCAG 3'; 3'IE2.100,
5' ACGAATTCGiGATC-CIGATTAGGAATCGATACCGG
CATGATTG 3'; 3'IE2.291, 5' ACGAATTCGfIATCCTGA
UAGGCTCGAGGTCACGGATG 3'; 3'IE2.456, 5' ACG
AATTCGGATCCTGATTACACTTTlGGGTGGATGTGTC
3'; and 3'IE2.539, 5' ACGAATTCGGATCCTGATTACGT
CTCGTAGATAGGCAGCATG 3'.
The 5' amplimers contain a BamHI site adjacent to a
initiation codon (underlined) such that the resulting product
would be cloned in frame with the GST gene. The 3'
amplimers contain a BamHI site adjacent to a stop codon
(TGA, underlined) for easy detection of cloned inserts
oriented in the wrong direction. PCR reactions were com-
posed of 10 ng of DNA template, 10 mM KCl, 10 mM
(NH4)2SO4, 20 mM Tris-HCl (pH 8.8), 2 mM Mg2SO4, 0.1%
Triton X-100, 100 ,ug of bovine serum albumin per ml, 200
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pIM deoxynucleoside triphosphate (Pharmacia, Piscataway,
N.J.), 10 pmol of each amplimer, and 1 U of Vent DNA
polymerase (New England BioLabs, Beverly, Mass.) over-
laid with mineral oil. Amplification was performed with a
program consisting of 2 initial cycles of 94°C for 2 min, 55°C
for 2 min, and 72°C for 3 min followed by 20 cycles of 94°C
for 1 min, 55°C for 1 min, and 72°C for 2 min and 2 final
cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 5 min
to create the various constructs mentioned above. A sample
of each PCR reaction was analyzed by gel electrophoresis,
and the remainder was purified with Geneclean (Bio 101
Inc., La Jolla, Calif.) according to the manufacturer's spec-
ifications. The isolated PCR-amplified DNA was digested
with BamHI for at least 2 h and subjected to gel electro-
phoresis through a 1% agarose gel. The PCR fragments were
isolated from agarose by Geneclean as specified by the
manufacturer and ligated into the BamHI site of the
pGEX-2T (Pharmacia) polylinker, which had been treated
with calf intestinal phosphatase (Promega, Madison, Wis.).
Double-stranded sequencing was performed on positively
expressed constructs with the Sequenase kit (U.S. Biochem-
ical Corp., Cleveland, Ohio) and Sequentide (Amersham) as
directed by the manufacturer.
Expression and purification of GST fusion proteins. Expres-
sion of GST fusion proteins was as described by Smith and
Johnson (52). Fresh overnight cultures of Escherichia coli
[BL21(DE3)pLysS; Novagen] transformed with either
pGEX-2T or one of the recombinants were diluted 1:20 in
Luria-Bertani medium with both chloramphenicol (34 ,ug/ml)
and ampicillin (50 pg/ml). After 2 h of growth in a 37°C
shaker, isopropyl-3-D-thiogalactopyranoside (IPTG) (Sigma)
was added to a final concentration of 0.1 mM, and incubation
was continued for an additional 2 h. Cultures were pelleted
by centrifugation at 2,500 x g for 10 min at 4°C and
resuspended in 1 ml of ice-cold lx PBS for every 10 ml of
original culture volume; aliquots of 1 ml were stored at
-70°C. Prior to each experiment, an aliquot was lysed by
rapid thawing at 37°C and mild sonication. After centrifuga-
tion at 14,000 x g for 2 min at 4°C, fusion proteins were
recovered from the supernatant by rocking with 25 ,ul of
glutathione-Sepharose 4B beads (Pharmacia) for 15 min at
4°C. The glutathione-Sepharose beads complexed with fu-
sion proteins were washed three times with ELB+ (250 mM
NaCl, 0.1% Nonidet P-40, 50 mM HEPES [pH 7.0], 5 mM
EDTA, 0.5 mM DTT, 1 mM PMSF). For analysis of bound
fusion proteins, the beads were boiled in Laemmli sample
buffer (31) and loaded onto a sodium dodecyl sulfate (SDS)-
10% polyacrylamide gel. After electrophoresis, fusion pro-
teins were visualized by Coomassie blue staining.
IE2 binding assay. Following expression and recovery of
GST fusion proteins on glutathione-Sepharose beads, the
bead-fusion protein complexes were equilibrated with three
washes of ELB+ buffer. The beads were incubated at 4°C for
2 h with either [35S]methionine- or 32pi- labeled whole-cell,
nuclear, cytoplasmic, or programmed rabbit reticulocyte
lysates (see below) precleared with GST-coated beads. The
bead-associated complexes were then washed five times in 1
ml of ELB+ buffer, pelleted, and boiled for 2 min in Laemmli
sample buffer. Interacting proteins were resolved by electro-
phoresis through an SDS-10% polyacrylamide gel and visu-
alized by either fluorography or autoradiography.
In vitro transcription and translation. PCR was used to
amplify the coding regions of IE1 and IE2 from the IE cDNA
clones pGEM4-1T (IE1) and pGEM4-2T (IE2; 84 kDa) with
the following primers: 5'IE1&2Hind, 5' CCCAAGCTTC




The 5'IE1&2Hind amplimer contains a HindIII restriction
site adjacent to a Kozak sequence before the start codon
(underlined) to allow for efficient translation, and the 3'
amplimers contain a SalI restriction site (underlined). PCR
amplification and isolation of products were conducted as
described above. Following HindIII-Sall double digestion,
the PCR products were cloned directionally into the HindIII
and SalI site of pBS+ (Stratagene, La Jolla, Calif.). The
resulting phagemids, pBS+.IE1 and pBS+.IE2, linearized
with EcoRI, were in vitro transcribed with the T3 RNA
polymerase in vitro transcription kit (Promega) in the pres-
ence of 0.5 mg of bovine serum albumin per ml. Approxi-
mately 2 ,g of RNA was added to a reaction containing 35 ,u
of micronuclease-treated rabbit reticulocyte lysate (Pro-
mega), 1 RI of 1 mM amino acids minus methionine, 1 Rl of
RNasin (Promega), 6 RI of (35S]methionine (1,200 Ci/mmol,
10 mCi/ml; Dupont, NEN Research Products), and water to
a 50-ml total volume. The reaction was incubated at 30°C for
2 h, and an aliquot examined by SDS-polyacrylamide gel
electrophoresis (PAGE) was visualized by autoradiography.
Western blot (immunoblot) analysis. Cellular proteins in-
teracting with IE2 were enriched by running cellular extracts
from approximately 108 cells over a GST-Sepharose column
three times to remove GST binding proteins and then
through a GST-IE2-Sepharose column three times. The
loaded GST-IE2 column was washed with several column
volumes of ELB+, and the IE2 interacting proteins were
eluted with increasing concentrations of salt (350, 450, 550,
650, and 800 mM NaCl). A fraction of each elutent was
boiled in Laemmli sample buffer and loaded onto SDS-
polyacrylamide gels. Following electrophoresis, the proteins
were transferred to nitrocellulose as described by Towbin et
al. (65). The blots were blocked for 1 h in 5% (wt/vol) nonfat
dry milk dissolved in TBS-0.1% Tween 20 and washed four
times with TBS-0.1% Tween 20. The blots were then reacted
with a 1:1,000 dilution of an antiTATA-binding protein
(TBP) antibody (gift from Ray Jupp and Jay Nelson of the
Oregan State University, Portland) for 1 h at room temper-
ature. After extensive washing with TBS-0.1% Tween 20,
the blots were probed with a 1:5,000 dilution of horseradish
peroxidase-conjugated anti-rabbit immunoglobulin G (Amer-
sham). Following extensive washing, the blots were devel-
oped by enhanced chemiluminescence (Amersham) accord-
ing to manufacturer's specifications.
Far-Western analysis. pGEX-2TK.IE2 was cloned by PCR
amplification with the 5'IE1&2 and 3'IE2 amplimers and
pGEM4-2T (IE2; 84 kDa) and was then inserted into the
BamHI site of the pGEX-2TK (5, 25) polylinker in frame
with the GST gene containing a heart muscle kinase site
(GSTK). Expression of GSTK-IE2 proteins was conducted
as described above. Following isolation on glutathione-
Sepharose 4B (Pharmacia) beads, GSTK and GSTK-IE2
were labeled with [-y-32P]ATP (150 ,Ci; 6,000 Ci/mmol;
Amersham) and heart muscle kinase (Sigma) as previously
described (5, 25). Proteins from cellular lysates were sepa-
rated by SDS-10% PAGE and electroblotted onto nitrocel-
lulose in 192 mM glycine-25 mM Tris-and 0.01% SDS. After
transfer and blocking, proteins were renatured in situ (5) and
then reacted with labeled GSTK or GSTK-IE2 as described
previously (25). The blot was then washed extensively with
hybridization buffer (25), dried, and autoradiographed.
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FIG. 1. Construction, expression, and purification of GST fusion
proteins. (A) Diagrammatic representation of the GST-IE2 fusion
protein and deletion mutants used in this study. Transactivation,
repression, and C-terminal acidic domains are represented by the
light-grey, dark-grey, and black regions, respectively. pGEX.IE2,
pGEX.IE2.1-539, pGEX.IE2.1-291, pGEX.IE2.1-100, pGEX.IE2.
97-579, pGEX.IE2.97-539, pGEX.IE2.97-456, pGEX.IE2.285-539,
pGEX.IE2.532-579, and pGEX.IE2-55K were cloned by PCR am-
plification of the appropriate coding regions which correspond to
known functional domains (39, 41, 47-49, 55) ofIE2. (B) Bacterial
clones containing the pGEX-2T or the recombinant pGEX-2T clones
were grown in the presence of IPTG, sonicated, and incubated with
glutathione-Sepharose beads. After purification and elution, the
recombinant proteins were electrophoresed on an SDS-10% poly-
acrylamide gel and stained with Coomassie blue.
RESULTS
Expression ofIE2 (84 kDa) andIE2 deletions as GST fusion
proteins. To test the ability of the 84-kDa IE2 protein to
interact with cellular proteins, a series of GST-IE2 fusion
proteins that corresponded to either the 84-kDa IE2 or
previously described functional domains of IE2 was gener-
ated (Fig. 1A). The complete coding region and domains of
IE2 were PCR amplified from an IE2 cDNA and cloned into
a procaryotic expression vector, pGEX2T. After IPTG in-
duction, the fusion protein was affinity purified on glutathi-
one-Sepharose beads and analyzed for expression on a
SDS-polyacrylamide gel stained with Coomassie blue (Fig.
1B). Expression of the pGEX2T.IE2-84K clone results in a
protein of approximately 110 kDa, and the fusion deletions
corresponded to their predicted molecular weights. The
fidelity of the recombinant GST-IE2 fusion proteins was
confirmed by Western blot analyses using either a Dupont
monoclonal antibody against early nuclear protein (recogniz-
es both IE1 andIE2), anIE2-specific monoclonal antibody
(12IE2), or a rabbit polyclonal peptide antibody against the C
terminus ofIE2 (57). The IE antibodies correctly recognized
the bacterially expressed fusion proteins but not GST alone
(data not shown).
The 84-kDaIE2 protein interacts with several cellular
proteins. To identify cellular proteins which interact with the
84-kDaIE2 protein, the GST-IE2 fusion protein (Fig.1B,
1-579) bound to glutathione-Sepharose beads was used as an
affinity matrix to pull down protein complexes that may
interact withIE2. As illustrated in Fig. 2A, minimal back-
ground was detected when precleared [ S]methionine- (lane
1) or 32Pi- (lane 2) labeled HEL lysates were incubated with
GST coated beads. However, several proteins ranging from
>200 to 19 kDa affinity purified with GST-IE2-coated beads
from the [35S]methionine-labeled HEL lysate (lane 3).IE2-
associated phosphoproteins of >200, 150, 60, 37, 34, and 19
kDa could be detected in the 32Pi-labeled HEL lysate incu-
bated with GST-IE2-coated beads (lane 4). Unproportional
phosphorylation of proteins was observed with proteins of
sizes around 37 and 34 kDa. The interaction betweenIE2
and pp37 or pp34 may depend on their phosphorylation
states. After a longer exposure, a few background bands of
58, 45, and 25 kDa were detected when labeled lysates were
incubated with GST-coated beads. These particular protein
interactions appear to have been enhanced in the presence ofGST-IE2 but were considered to be nonspecific and were not
included in this study.
The cellular proteins complexed to GST-IE2 were washed
with increasing salt concentrations in order to better define
the stability of binding in the complexes. At NaCl concen-
trations of 250 mM (the salt concentration of the ELB+
solution), the GST-IE2 and cellular protein complexes re-
mained intact. When salt concentrations reached between
350 and 550 mM, proteins with molecular masses of 150, 105,
95, 85, 68, and 60 kDa and small portions of proteins of 52,
45, 42, 40, 37, 34, and 32 kDa disassociated. The remaining
peptides with sizes of 74, 72, 70, and 62 kDa and the majority
of proteins of 52, 45, 42, 40, 37, 34, 32, and 27 kDa remained
bound to the GST-IE2 Sepharose beads even when salt
concentrations in the ELB+ buffer reached as high as 0.8 M
(data not shown). The 45- and 42-kDa proteins existing
within the complexes could be detected in GST-Sepharose
controls and were considered to be nonspecific.
The function and nuclear localization ofIE2 suggest that
these cellular proteins would also be located in the nucleus.
To determine whether these proteins were nuclear or cyto-
plasmic, 35S-labeled HEL cells were harvested to yield
nuclear and cytoplasmic fractions. IE2 binding assays were
performed on both fractions and whole cell lysate for com-
parison. As seen in Fig. 2B, the detection of cellular proteins
that interact with IE2 was enhanced in the nuclear fraction
(lane 4) and not visible in the cytoplasmic fraction (lane 3).
Some faint bands were detected in the cytoplasmic fraction
that comigrate with similar bands from the nuclear fraction.
There are two possible explanations for this observation: (i)
there was some leakiness of proteins from the nuclei during
preparation of the cytoplasmic fraction or (ii) IE2 is inter-
acting with proteins that were recently translated and had
not been translocated to the nucleus. Interestingly, the
infected lysate (24 h postinfection) used in the IE2 binding
assay (Fig. 2B, lane 5) generated a banding pattern similar to
that seen in uninfected lysate (lane 2); however, the intensity
of some bands was lower, suggesting possible competition
between the endogenous IE2 in the infected lysate withGST-IE2 or decreasing of these proteins synthesized upon
J.VIROL.






























FIG. 2. Detection of cellular protein-IE2 protein interactions by IE2 binding assays. (A) Autoradiograph showing the results of a IE2
binding assay with either [35S]methionine- and 32Pi-labeled HEL extracts precleared with GST-coated beads. Precleared [35S]methionine-
labeled lysate was incubated with either GST- (lane 1) or GST-IE2- (lane 3) coated beads, and precleared 32Pi-labeled lysate was incubated
with either GST- (lane 2) or GST-IE2- (lane 4) coated beads. Interacting proteins were resolved by SDS-10% PAGE and visualized by
fluorography. (B) IE2 binding assay conducted with either precleared 35S-labeled whole-cell lysate (lane 2), cytoplasmic fraction (lane 3),
nuclear fraction (lane 4), or 24-h-infected, whole-cell lysate (lane 5) in the presence of either GST- (lane 1; 35S-labeled whole-cell lysate is
shown) or GST-IE2-coated beads.
viral infection. The 80-kDa protein that is present only in the
infected lysate may be either a cellular protein induced by
infection or a viral protein which can interact with IE2. The
latter seems to be favored since further data in this report
demonstrate IE2-IE2 protein interactions. These experi-
ments demonstrate the ability of IE2 to interact specifically,
either directly or indirectly, with approximately 16 cellular
proteins that are nuclear in origin, a subset of which are
phosphorylated. Additionally, the infected lysate exhibits a
new IE2 protein interaction with either an induced cellular
protein or a virus-specific protein.
Mapping cellular protein-IE2 protein interactions to do-
mains of IE2. Regions of IE2 responsible for transactivation
of early promoters and autoregulation of the MIEP have
been mapped through transient transfection assays by sev-
eral groups (48, 49, 55). We hypothesize that these domains
within IE2 would be involved in protein-protein interactions
that elicit the observed regulation of various promoters. To
characterize proteins that interact with these domains of
IE2, several GST-IE2 deletion contructs were designed (Fig.
1A). The expressed GST-IE2 deletions (Fig. 1B) were incu-
bated with either [35S]methionine- (Fig. 3A) or 32Pi- (Fig. 3B)
labeled HEL lysates as previously described. Two major
groups of cellular proteins required different functional do-
mains of IE2 for protein-protein interactions. The assem-
blage that appeared to interact with a region (amino acids 97
to 290) encompassing a transactivation domain included
150-, 72-, and 54-kDa proteins. Another assemblage which
appeared to interact with a region (amino acids 285 to 539)
required for transactivation and autoregulation by IE2 in-
cluded proteins of >200, 52, 37, 34, and 32 kDa. A 60-kDa
protein interacted with the N-terminal transactivation do-
main (amino acids 1 to 100). The first 85 amino acids of IE2
are shared with IE1; however, preliminary data suggest the
interaction between the 60-kDa protein and IE2 requires an
additional 15 amino acids (86 to 100) since this cellular
protein failed to interact with GST-IE1 (data not shown).
Amino acids 1 to 100 appeared to be dispensible for the
interaction between IE2 and the >200-, 68-, 52-, 37-, 34-, 32-,
and possibly the 150-, 72-, and 54-kDa proteins. However,
both the 95- and 85-kDa proteins require the full-length IE2
for their interaction. The 74- and 27-kDa proteins interacted
with all GST-IE2 deletions and are considered nonspecific.
In addition to the interactions described above, new bands
appeared with various IE2 deletions. Since these bands were
not represented in the pool of proteins which interacted with
the full-length IE2, the authenticity of their interaction with
IE2 is questionable and assumed to be nonspecific. The
results from these experiments are summarized in Table 1.
These experiments reveal the ability of IE2 to interact
with what appears to be two complexes and several addi-
tional, individual proteins. These proteins associate with
functional domains required for transactivation or both
transactivation and autoregulation.
Identification of direct protein interactions between cellular
proteins and IE2 via far-Western blotting. The binding assay
utilized in the previous experiments was unable to distin-
guish between direct and indirect IE2 protein interactions.
To identify cellular proteins directly interacting with IE2, a
far-Western blotting technique was employed with IE2 as a
probe to detect direct interactions. The coding region of IE2
was subcloned into pGEX-2TK (5, 25), which contains a
heart muscle kinase domain downstream of the thrombin
cleavage site. Initially, a renatured Western blot of a GST-
IE2 binding assay was probed with 32P-labeled GSTK or
GSTK-IE2 fusion protein. This resulted in a heavily labeled
band of approximately 110 kDa plus lower bands on a short
exposure which probably corresponded to bacterially ex-
pressed GST-IE2; however, GSTK-IE2 did not cross-react
with GST alone. This result indicated that IE2 may be
capable of interacting with itself; this will be discussed later.
To avoid potential background interference introduced by
GST-IE2, whole-cell HEL lysates were Western blotted
along with an IE2 binding assay from 35S-labeled HEL
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FIG. 3. Detection of cellular protein-IE2 protein interactions with various GST-IE2 deletions. Precleared [35S]methionine- (A) or 32pi (B)
labeled HEL lysates were incubated with beads coated with the following (lanes): GST (GST), GST-IE2 (1-579), GST-IE2 (1-539), GST-IE2
(1-291), GST-IE2 (1-100), GST-IE2 (97-579), GST-IE2 (97-539), GST-1E2 (285-539), or GST-IE2 (532-579). Bound proteins were separated by
SDS-10% PAGE and visualized by fluorography (A) or autoradiography (B).
lysates. The whole-cell HEL proteins resolved by SDS-
PAGE were transferred to nitrocellulose, renatured, and
probed with 32P-labeled GSTK-1E2. The results were com-
pared with those of an IE2 binding assay resolved on the
same SDS-polyacrylamide gel and transferred along with the
whole-cell lysates. As illustrated in Fig. 4A, IE2 directly
interacts with a subset of cellular proteins (150-, 95-, 74- or
72-, 60-, 54-, or 52-, 34-, or 32-, 27-, and 19-kDa proteins)
similar in size to those identified in the binding assays. In
addition, a new cellular protein of approximately 120 kDa
was found to interact with IE2 directly and not with the
control probe, GSTK, by this method. The nature of this
TABLE 1. Summary of cellular protein interactions with
IE2 deletions
Protein Interaction with IE2 with the following amino acids deleted'
(size [kDaJ) 1-579 1-539 1-291 1-100 97-579 97-539 285-539 537-579
>200b + + - - + + + -
150c + + + - + +
95d + - - - - _ _ _
85d + - - - - _ _ -
74" + + + + + + + +
72C + + + - + + - _
68g + - - - + - - -
60g + + + + - - _ _
54c + + + - + + - -
52" + + - - + + + -
37b + + - - + + + -
34" + + - - + + + -
32b + + - - + + + -
27e + + + + + + + +
irb + + - - + + + -
a +, interaction; -, no interaction.
bA group of-cellular proteins found to interact with IE2 between amino
acids 285 and 539.
c Another group of proteins found to interact with IE2 between amino acids
97 and 285.
d Proteins requiring full-length IE2 for their interaction with IE2.
e Cellular proteins found to interact with all deletions and assumed to be
nonspecific.
f Cellular protein requiring amino acids 97 to 579 for its interaction with IE2.
g A protein found to interact with the N terminus between amino acids 1
and 100.
protein interaction is unknown, although this result was
consistent between experiments. However, these results
indicate that several cellular proteins interact directly with
IE2.
It was previously reported that IE2 can interact directly
with in vitro-translated TBP (17). To demonstrate that GST-
IE2 is able to interact with TBP made in vivo, whole-cell
HEL lysates were passed over a GST affinity column prior to
being loaded on a GST-IE2 affinity column. Elutions of
increasing salt concentrations were collected and subjected
to Western blot analysis using an aTBP antibody (gift of Ray
Jupp and Jay Nelson). As shown in Fig. 4B, aTBP antibody
reacted with a protein of approximately 38 to 40 kDa. This
protein eluted from the GST-IE2 column with salt concen-
trations of up to 450 mM suggesting a stable protein-protein
interaction between IE2 and TBP. The molecular mass of
this protein corresponds to recombinant human TBP ex-
pressed in rabbit reticulocyte lysates (27, 46). This experi-
ment demonstrates that IE2 can associate with human
TATA-binding protein made in vivo in agreement with a
previous report of results with in vitro-made protein (17).
The C-terminal region of the 84-kDa IE2 protein conveys
IE2-1E2 protein interactions. To investigate the possibility of
IE2-IE2 interactions, IE2 binding assays were performed
with rabbit reticulocyte lysates programmed with either IE1
or IE2 (84 kDa) in vitro-transcribed RNA. As shown in Fig.
SA, the 35S-labeled proteins did not interact with either
beads alone (lanes 3 and 4) or GST-coated beads (lanes 5 and
6). However, IE2-programmed lysate did interact with GST-
IE2- (lane 10) but not with GST-IE1- (lane 8) or GST-IE2-
55K-coated beads (lane 11). It was also noted that IEl-
programmed lysates did not interact with either GST-IE1
(lane 7) or GST-IE2 (lane 9). To confirm these results,
far-Western analyses were performed on immobilized GST,
GST-IE1, and GST-IE2 proteins with either 32P-labeled
GSTK or GSTK-IE2 proteins. As seen in Fig. SB, GSTK-
IE2 interacted directly with GST-IE2 but not with GST or
GST-IE1.
The IE2-IE2 interacting domain was located by using the
previously described GST-IE2 deletions plus an additional
deletion (GST-IE2.97-456) that removed a potential coiled-
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FIG. 4. Direct interactions between several cellular proteins and
IE2. (A) Western blot of HEL cell lysate which was renatured and
probed with 32P-labeled GSTK (lane 3) or GSTK-E2 (lane 4).
Far-Western blots were compared to an IE2 binding assay of
precleared, [35S]methionine-labeled lysates incubated with either
GST- (lane 1) or GST-1E2- (lane 2) coated beads and resolved by
electrophoresis on the same SDS-10% polyacrylamide gel and
electroblotted onto nitrocellulose. The IE2 binding assay and far-
Western blots were visualized by autoradiography. (B) Western blot
analysis with an aTBP polyclonal antibody was performed on
fractions of IE2-associated proteins eluted from a GST-IE2 column
by increasing salt concentrations. A protein with a molecular mass
similar to that of TBP was found associated with IE2 in the 350 mM
and 450 mM salt elutions.
with the following deletions: 1 to 539, 97 to 579, 97 to 539,
and 285 to 539. This interaction was not detected with the 97
to 456 deletion, which suggested that amino acids 456 to 539
were required. This region contains two amphipathic ca-he-
lices separated by a short a-turn as predicted by the Chou-
Fasman algorithm (9).
DISCUSSION
The mechanism(s) by which 1E2, alone or in cooperation
with IE1, transactivates viral and cellular promoters and
autoregulates the MIEP is unknown at this time. It is known
that 1E2 binds directly to the CRS element at the cap site in
the MIEP, but the mechanism of downregulation is specu-
lative. IE2 has not been shown to bind to specific sequences
in other promoters, and the current thought is that 1E2 may
direct its influence through protein-protein interactions.




FIG. 5. Detection of IE2-IE2 interactions. (A) [35S]methionine-
labeled IEl- (lane 1) or IE2-programmed (lane 2) rabbit reticulocyte
lysates were used in IE2 binding assays. IEl- and IE2-programmed
rabbit reticulocyte lysates were incubated with glutathione-
Sepharose beads alone (lanes 3 and 4, respectively) or with beads
coated with GST (lanes 5 and 6, respectively), GST-IE1 (lanes 7 and
8, respectively), GST-IE2 (lanes 9 and 10, respectively), or GST-
IE2.55K (IE2-programmed lysate only, lane 11). (B) Purified and
eluted GST (lane 1), GST-IE1 (lane 2), and GST-IE2 (lane 3) were
resolved by SDS-10% PAGE in triplicate for far-Western analysis.
The first panel is an SDS-10% polyacrylamide gel stained with
Coomassie blue; the second and third panels are duplicate Western
blots reacted with 32P-labeled GSTK and GSTK-IE2, respectively.
by IE2 is to identify the cellular and/or viral proteins that
interact directly or indirectly with this transactivator-repres-
sor.
IE2 interaction with cellular proteins. In this report, we
demonstrate several cellular proteins ranging from >200 to
19 kDa that interact with the 84-kDa IE2 protein. Of these, a
subset were identified as phosphoproteins and all appeared
to be nuclear proteins. Additionally, a protein of approxi-
mately 80 kDa appears to be specific to infected lysates. The
cellular protein-IE2 interactions, including two distinct pro-
tein complexes and several individual proteins, were
mapped to specific functional domains of IE2 known to be
required for transactivation or both transactivation and
autoregulation. By far-Western analysis, a subset of proteins
(150, 95, 74 or 72, 60, 54 or 52, 34 or 32, 27 and 19 kDa) was
demonstrated to interact directly with IE2. As a control for
the binding assays, GST-IE2 was shown to interact with
TBP made in vivo by affinity purification. Thus, it is quite
possible that the 37-kDa protein detected only in the 32Pi
HEL lysate might be TBP, based on its size and phosphor-
ylation. The far-Westerh technique is currently being used to
A
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FIG. 6. Location of the IE2-IE2 interaction domain. IE2 binding
assays were performed with an IE2-programmed rabbit reticulocyte
lysate incubated with the following (lanes): glutathione-Sepharose
beads (beads) or beads coated with GST (GST), GST-IE2 (1-579),
GST-IE2 (1-539), GST-IE2 (1-291), GST-IE2 (1-100), GST-IE2 (97-
579), GST-IE2 (97-456), GST-IE2 (97-539), GST-IE2 (285-539), or
GST-IE2 (532-579).
screen a cDNA expression library derived from uninfected
HEL cells to identify the IE2-associated proteins.
These studies were conducted with a bacterially expressed
fusion protein of IE2 and were based on the assumption that
the fusion protein would interact with cellular and/or viral
proteins in a manner modeling in vivo interactions; however,
it remains to be determined whether mammalian expressed
IE2 will associate with the cellular proteins identified in this
study as well as additional proteins which were not detected
because of either posttranslational modifications of IE2 or
steric hindrance from the GST fusion. Nevertheless, this
experimental approach has been efficiently utilized to iden-
tify and clone cellular proteins that interact with c-fos and
the retinoblastoma protein, p105-Rb (5, 25, 26). In addition,
it is possible that these results of fusion precipitations are not
free protein-protein interactions but rather DNA-mediated
protein-protein interactions in which small pieces of contam-
inating DNA nonspecifically bridge proteins. To exclude this
possibility, we have performed fusion precipitation in the
presence of 100 ,ug of ethidium bromide per ml as described
by Lai and Herr (32). No major variation of the protein
binding pattern was found between fusion precipitations
with ethidium bromide and controls. However, higher back-
ground noise was observed (data not shown). Therefore, the
phenomenon of DNA-mediated protein-protein interaction
should be very limited in this study. The nature of the
far-Western experiments raises the possibility that certain
proteins that directly interact with IE2 may go undetected
because of their inability to properly renature. This short-
coming was demonstrated by our inability to detect mam-
malian-expressed TBP by far-Western analysis.
Hagemeier et al. (17) demonstrated the ability of IE2 to
interact with the C terminus of in vitro-made TFIID, and our
studies confirm that in vivo-expressed TBP interacts with
IE2. It is possible that IE2 may also interact with additional
members of the preinitiation complex since proteins similar
in size to others in the preinitiation complex were found to
interact with IE2 in this study. The interaction between
TFIID and IE2 is similar to that of the IE protein of
adenovirus, ElA (36), and other herpesvirus IE proteins,
including Z of EBV (38).
Other IE proteins (ElA, ICP4, and Z) have been shown to
have transactivation mechanisms in addition to those involv-
ing direct interactions with TFIID. These include binding to
a specific DNA sequence in the case of ICP4 and Z (6, 14, 16,
22, 37, 38, 43, 45, 60, 61) and interacting directly or indirectly
with another DNA-bound transactivator(s), thereby func-
tioning as a bridging molecule between the transactivator
and the preinitiation complex, as seen in ElA with ATF-2
(40). Recently, IE2 has been shown to bind specifically to a
DNA sequence, CRS, located at the transcriptional start site
of the MIEP (35). This sequence has been shown to be
essential for IE2 autoregulation (18, 39, 47, 49, 55). Simil-
iarly, HSV-1 ICP4 also binds to a sequence located down-
stream of the TATA box (43) to downregulate its promoter
(50). However, IE2 has not been shown to bind directly to
DNA sequences associated with the transactivation of pro-
moters in a manner similar to that of ICP4 (14, 29, 30, 43, 44).
Our current observations suggest that IE2 transactivating
ability is likely to be conveyed through direct or indirect
protein-protein interactions with cellular transcription fac-
tors.
HCMV is known to stimulate a GJ/S-like phase which
activates the cellular proliferation machinery. This event is
accomplished by increasing the expression of genes required
for proliferation or induction of the G1/S phase, resulting in
increased expression of these genes (e.g., DNA polymerase
a [20, 21], RNA polymerase [59], thymidine kinase [13],
topoisomerase II [3], ornithine decarboxylase [23], and
dihydrofolate reductase [66]). The major IE region has been
shown to be responsible for the induction of the dihydrofo-
late reductase promoter (66). This transactivation is associ-
ated with an E2F recognition site within the dihydrofolate
reductase promoter that is bound by an S-phase-like com-
plex composed of E2F, p107, cyclin A, and p33cdk2 (66).
Also, several other cellular andHCMV early promoters appear
to be regulated through an E2F recognition sequence(s); how-
ever, it remains to be determined whether the E2F-p107-
cyclin A-p33Cdk2 complex is involved directly in the transac-
tivation of these promoters. Promoters containing E2F
recognition sites such as the adenovirus E2 promoter can be
transactivated by IE2 alone, although this can be augmented
by IE1 (19, 49, 64). Thus, IE2 is a likely candidate for
stimulating E2F-mediated transactivation. Our observations
from binding assays found proteins (>200, 150, 120, 60, and
34 kDa) with molecular masses similar to those of the E1A-
and E2F-associated proteins which interact with IE2. It is
likely that the 32- to 34-kDa IE2-binding proteins may be
CDK2- or CDC2-related proteins. We are currently investi-
gating the ability of IE2 to interact directly with cellular
proteins known to be involved in regulating the transactivat-
ing ability of E2F.
Location ofthe domain responsible for 1E2-1E2 interactions.
By IE2-binding assays and far-Western analysis, we demon-
strated an IE2-IE2 interaction in a domain required for both
transactivation and autoregulation. This domain is located
between amino acids 456 and 539 and is predicted to contain
two amphipathic a-helices separated by a short ,-turn. This
motif is located adjacent to a putative TFIIIA-type zinc
finger (41) (Fig. 7). It remains to be determined whether the
zinc finger motif is responsible for recognition of the CRS
element by IE2; however, the close proximity of these
putative elements may play a significant role in autoregula-
tion and transactivation. Site-directed mutagenesis is being
performed on these a-helical regions to determine their role
in the IE2-IE2 interaction. Preliminary results from UV-
cross-linking studies using in vitro-translated 35S-IE2 protein
in the presence of ditho-bis-succinimidylpropionate indicate
IE2 interactions may be in the form of a dimer. The
interaction after cross-linking can be disrupted in the pres-
ence of DTT (our unpublished data). Further studies using
expressed proteins to confirm IE2 multimerization and to
elucidate its functional role in vivo are needed.
The experiments presented in this report also demonstrate
J. VIROL.
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FIG. 7. Location of a putative zinc finger and helix-turn-helix
motif in the C terminus of the 84-kDa IE2 protein. IE2-IE2 interac-
tions were mapped to a region between amino acids 456 and 539.
This region contains an amphipathic a-helix (amino acids 463 to
482), a short 1-turn (amino acids 483 to 488), and then another
a-helix (amino acids 489 to 513). A putative zinc finger (amino acids
428 to 452) is located upstream of the helix-turn-helix motif.
the inability of IE2 to form heterodimers with IEL. However,
these results do not discount the ability of IE2 to interact
with IE1 indirectly by other means. The 55-kDa IE2 protein
fails to transactivate HCMV early promoters as well as
downregulate the MIEP (18, 41, 48, 55). This protein con-
tains neither the zinc finger nor the helix-turn-helix motif and
does not dimerize with IE2 (Fig. 5A, lane 11). The 40-kDa
IE2 protein contains both motifs and would be expected to
dimerize with the 84-kDa IE2 protein. This late IE2 variant
is capable of downregulating the MIEP but fails to transac-
tivate cellular and HCMV early promoters (18, 47, 49) and
thus most likely functions as a trans-dominant repressor.
The bovine papillomavirus expresses a similar protein, E2-
TR, which contains the dimerization and DNA binding
domains but not the transactivation region (8, 33, 34).
Preliminary results from DNA electrophoretic mobility shift
assays using the IE2 CRS element of MIEP indicate that IE2
multimerization is not essential for IE2 binding to the CRS
sequence (our unpublished data).
Further characterization of the domain within IE2 that is
required for IE2-IE2 interaction will be necessary to deter-
mine whether IE2 oligomerization is required for transacti-
vation, autoregulation, or both. Additionally, identification
of the cellular proteins which interact with IE2 will be of
utmost importance in elucidating the mechanism(s) involved
in transactivation of homologous and heterologous promot-
ers by IE2.
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